[HTML][HTML] Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid
Background Anti-angiogenic medications, one of cancer chemo preventive mechanism were
permitted for different cancers. Nevertheless, major primary and secondary resistance …
permitted for different cancers. Nevertheless, major primary and secondary resistance …
[PDF][PDF] Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid
J Ekowati, KA Nofianti, MN Yunita, IS Hamid… - 2023 - pdfs.semanticscholar.org
Background: Anti-angiogenic medications, one of cancer chemo preventive mechanism
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid.
J Ekowati, KA Nofianti, MN Yunita, IS Hamid… - Journal of Public …, 2023 - europepmc.org
Background Anti-angiogenic medications, one of cancer chemo preventive mechanism were
permitted for different cancers. Nevertheless, major primary and secondary resistance …
permitted for different cancers. Nevertheless, major primary and secondary resistance …
Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid.
J Ekowati, KA Nofianti, MN Yunita… - Journal of Public …, 2023 - search.ebscohost.com
Background: Anti-angiogenic medications, one of cancer chemo preventive mechanism
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid
J Ekowati, KA Nofianti, MN Yunita… - Journal of Public …, 2023 - publichealthinafrica.org
Background: Anti-angiogenic medications, one of cancer chemo preventive mechanism
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid.
J Ekowati, KA Nofianti, MN Yunita, IS Hamid… - 2023 - cabidigitallibrary.org
Background: Anti-angiogenic medications, one of cancer chemo preventive mechanism
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid
J Ekowati, KA Nofianti, MN Yunita… - Journal of public …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Anti-angiogenic medications, one of cancer chemo preventive mechanism were
permitted for different cancers. Nevertheless, major primary and secondary resistance …
permitted for different cancers. Nevertheless, major primary and secondary resistance …
Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid
J Ekowati, KA Nofianti, MN Yunita… - Journal of Public …, 2023 - scholar.unair.ac.id
Background: Anti-angiogenic medications, one of cancer chemo preventive mechanism
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
[PDF][PDF] Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid
J Ekowati, KA Nofianti, MN Yunita… - Journal of Public …, 2023 - publichealthinafrica.org
Background: Anti-angiogenic medications, one of cancer chemo preventive mechanism
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
[引用][C] Synthesis, anti-angiogenic activity and prediction toxicity of (E)-3-(3-methoxyphenyl) propenoic acid
J Ekowati, KA Nofianti, MN Yunita, IS Hamid… - 2023 - europepmc.org
Background: Anti-angiogenic medications, one of cancer chemo preventive mechanism
were permitted for different cancers. Nevertheless, major primary and secondary resistance …
were permitted for different cancers. Nevertheless, major primary and secondary resistance …